SEC Comment Letter for Tvardi Therapeutics, Inc. (TVRD) (CIK 0001346830) (TVRD) — Mar 22, 2017
Tvardi Therapeutics, Inc. (TVRD) (CIK 0001346830)
Date: March 22, 2017 · CIK: 0001346830 · Accession: 0000000000-17-009471
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-216657
Letter
Mail Stop 4546 March 22, 2017 Derek Chalmers, Ph.D., D.Sc. Chief Executive Officer Cara Therapeutics, Inc. 4 Stamford Plaza 107 Elm Street Stamford, Connecticut 06902
Re: Cara Therapeutics, Inc. Registration Statement on Form S-3 Filed March 13, 2017 File No. 333-216657
Dear Dr. Chalmers :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551 -6761 with any questions.
Sincerely,
/s/ Erin K. Jaskot, for
Show Raw Text
Mail Stop 4546 March 22, 2017 Derek Chalmers, Ph.D., D.Sc. Chief Executive Officer Cara Therapeutics, Inc. 4 Stamford Plaza 107 Elm Street Stamford, Connecticut 06902 Re: Cara Therapeutics, Inc. Registration Statement on Form S-3 Filed March 13, 2017 File No. 333-216657 Dear Dr. Chalmers : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551 -6761 with any questions. Sincerely, /s/ Erin K. Jaskot, for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Darren DeStefano Cooley LLP